Last edition
News about "Gemma Budd"
Aptar and Aceso Therapeutics Partner on Inhaled Antisense Therapy for Cystic Fibrosis
Aptar and Aceso Therapeutics collaborate to advance inhaled antisense therapy ACT-101 for cystic fibrosis through formulation development and device assessment.
Gemma Budd | 08/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members